Cargando…
Combined checkpoint inhibitor therapy causing diabetic ketoacidosis in metastatic melanoma
BACKGROUND: There has been a significant improvement in survival of advanced malignancies with the advent of checkpoint inhibitors. These newer treatment modalities come with a wide spectrum of unique side effects, termed immune related adverse events (irAE), ranging from mild skin rash to severe co...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735540/ https://www.ncbi.nlm.nih.gov/pubmed/29254501 http://dx.doi.org/10.1186/s40425-017-0303-9 |